1-4 of 4
restrictive cardiomyopathy with endomyocardial fibrosis
Close
Sort by
Journal Articles

ECP in the spotLIGHT

Ryan A. Wilcox
Journal: Blood
Blood (2019) 134 (16): 1275–1277.
https://doi.org/10.1182/blood.2019002790
Published: 2019
Journal Articles

The Effect of Initial Molecular Profile on Response to Recombinant Interferon Alpha (rIFNα) Treatment in Early Myelofibrosis

Richard T. Silver, Ariella Barel, Elena Lascu, BA,MA, Ellen K. Ritchie, MD, Gail J. Roboz, MD, Paul Christos, Attilio Orazi, MD, Duane C Hassane, PhD, Wayne Tam, MD PhD, Nicholas C.P. Cross, PhD
Journal: Blood
Blood (2016) 128 (22): 944.
https://doi.org/10.1182/blood.V128.22.944.944
Published: 2016
Journal Articles

Recombinant Interferon Alpha (rIFN) May Retard Progression Of Early Myelofibrosis By Reducing Splenomegaly and By Decreasing Marrow Fibrosis

Richard T. Silver, Elena Lascu, Eric J. Feldman, MD, Ellen Ritchie, MD, Gail J. Roboz, MD, Maria Teresa De Sancho, MD, MSc, Ruth Bauman, Attilio Orazi, MD
Journal: Blood
Blood (2013) 122 (21): 4053.
https://doi.org/10.1182/blood.V122.21.4053.4053
Published: 2013
Journal Articles

Cardiac Magnetic Resonance Imaging Detects Long-Term Fibrotic Changes in Patients with Primary Eosinophilic Disorders: A Cross-Sectional Study

Issa J. Dahabreh, Stavroula Giannouli, Sofia Mavrogeni, Haralampos M. Moutsopoulos, Michael Voulgarelis
Journal: Blood
Blood (2008) 112 (11): 5236.
https://doi.org/10.1182/blood.V112.11.5236.5236
Published: 2008